The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 176 (6) , 32S-38S
- https://doi.org/10.1016/s0002-9610(98)00218-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- ANALYSIS OF THE IN VITRO ACTIVITY OF TROVAFLOXACIN (CP-99,219) AGAINST BACTEROIDES SPECIESInfectious Diseases in Clinical Practice, 1996
- Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteersJournal of Antimicrobial Chemotherapy, 1996
- Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocciJournal of Antimicrobial Chemotherapy, 1996
- In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1995
- Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteersJournal of Antimicrobial Chemotherapy, 1995
- In Vitro Antimicrobial Activity of CP-99,219, a New 7-AzabicyclonaphthyridoneDrugs, 1995
- Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesAntimicrobial Agents and Chemotherapy, 1994
- Quinolone AntibacterialsDrugs, 1994
- Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureusThe Journal of Infectious Diseases, 1991
- Mechanisms of Fluoroquinolone Resistance in Staphylococcus aureusThe Journal of Infectious Diseases, 1991